Dr. Carmelle Munien

Carmelle Munien is a biomedical researcher whose work centers on molecular mechanisms driving cancer progression, with a particular focus on malignant melanoma. Affiliated with academic research in cellular and molecular biology, Munien has contributed to studies exploring how cell surface receptors influence tumor aggressiveness and metastatic behavior.

Her published research investigates the role of the 37 kDa/67 kDa laminin receptor in early and late stage melanoma. By examining receptor expression and its relationship to cellular adhesion and invasion, this work highlights how targeting specific molecular pathways can reduce metastatic potential. The study demonstrates the therapeutic promise of antibody-based strategies aimed at limiting tumor spread.

Based on the currently available publication record, the research profile reflects a focused contribution to experimental cancer biology, particularly in understanding receptor-mediated mechanisms of metastasis. The work underscores strengths in cell-based assays, molecular analysis, and translational approaches relevant to targeted melanoma therapy.